Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@PJamess69](/creator/twitter/PJamess69)
"@monaco_biotech Have you noticed this $PFE Pfizer (PFE) is also scheduled to release its Q2 2025 earnings report on August X 2025 before the market opens"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1948719225545052575) 2025-07-25 12:17:23 UTC XXX followers, XX engagements


"$MDGL good choice for big pharma looking for big revenues. Madrigal can generate stronger revenues with expansion to Europe in H2"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1947372329677234306) 2025-07-21 19:05:18 UTC XXX followers, XXX engagements


"$MRK $XBI Mercks current pipeline includes efinopegdutide a GLP-1/glucagon agonist in Phase X for MASH but it lags behind Rezdiffra. Acquiring $MDGL Madrigal would provide Merck with a market-leading approved asset complementing its cardiometabolic focus"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1947467167940645136) 2025-07-22 01:22:09 UTC XXX followers, XXX engagements


"$MDGL Citizens JMP analyst reiterated a Buy rating on Madrigal Pharmaceuticals today and set a price target of $470"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1947589635653177741) 2025-07-22 09:28:48 UTC XXX followers, XXX engagements


"All Bio potential Buyout Stocks strong today $BBIO $TGTX $CYTK $MDGL $XBI"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1944792353614491999) 2025-07-14 16:13:24 UTC XXX followers, XXX engagements


"$MDGL Exactly Jim. They are trying to push for more premium and they will get it.Its just a business tactic everyone will play"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1947828197355131117) 2025-07-23 01:16:45 UTC XXX followers, XXX engagements


"@Jabroni_16 @GYuengling24986 @MadrigalPharma where is the buyout"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1948483830366474398) 2025-07-24 20:42:00 UTC XXX followers, XX engagements


"@bioinvestor24 @badinvestor99 @Matthew_ABCD This is crazy.no competition for MASH . $MDGL is the first mover and has big advantage with it.CEO need to sell the company to $PFE or $BMY if he doesnt risk of company falling into competition from 2027.why take that risk Sell it"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1948847108703834147) 2025-07-25 20:45:33 UTC XXX followers, XXX engagements


"$MDGL $AKRO Deaths from Fatty Liver projected to DOUBLE by 2040 $XBI $PFE $BMY $VKTX"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1945146083392332063) 2025-07-15 15:39:00 UTC XXX followers, 2335 engagements


"$MDGL Someone adding AUG15 XXX strike calls in Madrigal ๐Ÿคจ๐Ÿง๐Ÿ˜"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1946293995342098681) 2025-07-18 19:40:23 UTC XXX followers, XXX engagements


"$MDGL With FDA approval already in hand and now robust IP protection Madrigal may have: - First-mover advantage in a multibillion-dollar market - A long runway of commercial exclusivity - A strategic edge in future partnerships M&A or pricing power"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1947101945455345899) 2025-07-21 01:10:53 UTC XXX followers, XXX engagements


"$MDGL Blowout Quarter is Obvious and Buyout is also Obvious ๐Ÿ˜"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1948093400286195884) 2025-07-23 18:50:35 UTC XXX followers, XXX engagements


"$MDGL Madrigals Valuation is Cheap and will get Bought out soon"  
![@PJamess69 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::954258105000480773.png) [@PJamess69](/creator/x/PJamess69) on [X](/post/tweet/1947316808370774096) 2025-07-21 15:24:41 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@PJamess69 "@monaco_biotech Have you noticed this $PFE Pfizer (PFE) is also scheduled to release its Q2 2025 earnings report on August X 2025 before the market opens"
@PJamess69 Avatar @PJamess69 on X 2025-07-25 12:17:23 UTC XXX followers, XX engagements

"$MDGL good choice for big pharma looking for big revenues. Madrigal can generate stronger revenues with expansion to Europe in H2"
@PJamess69 Avatar @PJamess69 on X 2025-07-21 19:05:18 UTC XXX followers, XXX engagements

"$MRK $XBI Mercks current pipeline includes efinopegdutide a GLP-1/glucagon agonist in Phase X for MASH but it lags behind Rezdiffra. Acquiring $MDGL Madrigal would provide Merck with a market-leading approved asset complementing its cardiometabolic focus"
@PJamess69 Avatar @PJamess69 on X 2025-07-22 01:22:09 UTC XXX followers, XXX engagements

"$MDGL Citizens JMP analyst reiterated a Buy rating on Madrigal Pharmaceuticals today and set a price target of $470"
@PJamess69 Avatar @PJamess69 on X 2025-07-22 09:28:48 UTC XXX followers, XXX engagements

"All Bio potential Buyout Stocks strong today $BBIO $TGTX $CYTK $MDGL $XBI"
@PJamess69 Avatar @PJamess69 on X 2025-07-14 16:13:24 UTC XXX followers, XXX engagements

"$MDGL Exactly Jim. They are trying to push for more premium and they will get it.Its just a business tactic everyone will play"
@PJamess69 Avatar @PJamess69 on X 2025-07-23 01:16:45 UTC XXX followers, XXX engagements

"@Jabroni_16 @GYuengling24986 @MadrigalPharma where is the buyout"
@PJamess69 Avatar @PJamess69 on X 2025-07-24 20:42:00 UTC XXX followers, XX engagements

"@bioinvestor24 @badinvestor99 @Matthew_ABCD This is crazy.no competition for MASH . $MDGL is the first mover and has big advantage with it.CEO need to sell the company to $PFE or $BMY if he doesnt risk of company falling into competition from 2027.why take that risk Sell it"
@PJamess69 Avatar @PJamess69 on X 2025-07-25 20:45:33 UTC XXX followers, XXX engagements

"$MDGL $AKRO Deaths from Fatty Liver projected to DOUBLE by 2040 $XBI $PFE $BMY $VKTX"
@PJamess69 Avatar @PJamess69 on X 2025-07-15 15:39:00 UTC XXX followers, 2335 engagements

"$MDGL Someone adding AUG15 XXX strike calls in Madrigal ๐Ÿคจ๐Ÿง๐Ÿ˜"
@PJamess69 Avatar @PJamess69 on X 2025-07-18 19:40:23 UTC XXX followers, XXX engagements

"$MDGL With FDA approval already in hand and now robust IP protection Madrigal may have: - First-mover advantage in a multibillion-dollar market - A long runway of commercial exclusivity - A strategic edge in future partnerships M&A or pricing power"
@PJamess69 Avatar @PJamess69 on X 2025-07-21 01:10:53 UTC XXX followers, XXX engagements

"$MDGL Blowout Quarter is Obvious and Buyout is also Obvious ๐Ÿ˜"
@PJamess69 Avatar @PJamess69 on X 2025-07-23 18:50:35 UTC XXX followers, XXX engagements

"$MDGL Madrigals Valuation is Cheap and will get Bought out soon"
@PJamess69 Avatar @PJamess69 on X 2025-07-21 15:24:41 UTC XXX followers, XXX engagements

creator/twitter::954258105000480773/posts
/creator/twitter::954258105000480773/posts